1413 Center Drive, Suite 220,
Park City, Utah 84098
DW Healthcare Partners is a healthcare focused private equity firm that partners with owners of mid-to late-stage companies. DW looks to invest in private, North American companies, primarily in the medical device, product, services, and specialty distribution sectors of healthcare. DW will invest from $15 to $60 million of equity capital to help facilitate growth or to fund acquisitions. DW looks for high-growth businesses with at least $5 million in EBITDA and prefers to be the majority investor. DW Healthcare Partners was formed in 2002 and is based in Salt Lake City, Utah.
Join Mergr to view the latest updates and news from Park City-based DW Healthcare Partners.
In the last 3 years, DW Healthcare Partners has invested in 5 companies.
DW Healthcare Partners’ most common sectors for investment are healthcare services (39%) and medical products (31%). The Firm’s most common investment types include buyout (lbo, mbo, mbi) (47%) and growth capital (35%). In total, DW Healthcare Partners has invested in 14 US states. Its largest (disclosed) acquisition occurred in 2007 when it acquired Reliant Renal Care for $50M.
In the last 3 years, DW Healthcare Partners has exited 3 companies. The Firm’s most common exit type is trade sale (65%). DW Healthcare Partners’ largest (disclosed) exit occurred in 2007 when it sold The Radlinx Group for $53M.
Join Mergr to view DW Healthcare Partners’ full profile and discover more middle-market private equity firms just like it.
No obligation. Cancel anytime.